Breaking News Instant updates and real-time market news.

BUD

AB InBev

$53.87 /

-1.23 (-2.23%)

12:07
07/05/22
07/05
12:07
07/05/22
12:07

AB InBev price target lowered to EUR 73 from EUR 74 at Deutsche Bank

Deutsche Bank analyst Mitch Collett lowered the firm's price target on AB InBev to EUR 73 from EUR 74 and keeps a Buy rating on the shares.

  • 28

    Jul

  • 19

    Sep

OTHER BREAKING NEWS FROM THE FLY

Earnings
Target Hospitality reports Q2 EPS 24c, consensus 17c » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
TH

Target Hospitality

$13.97 /

+0.12 (+0.87%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

07/12/22 Oppenheimer
Target Hospitality price target raised to $18 from $9 at Oppenheimer
TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

Recommendations
Enanta price target raised to $137 from $103 at JMP Securities » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
ENTA

Enanta

$71.21 /

+0.39 (+0.55%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENTA Enanta
$71.21 /

+0.39 (+0.55%)

ENTA Enanta
$71.21 /

+0.39 (+0.55%)

08/01/22 Oppenheimer
Enanta price target raised to $53 from $45 at Oppenheimer
07/29/22 Piper Sandler
Enanta's 'strong' EDP-235 data supports 'impressive' profile, says Piper Sandler
07/06/22 Evercore ISI
Enanta upgraded to Outperform at Evercore ISI ahead of COVID anti-viral data
07/06/22 Evercore ISI
Enanta upgraded to Outperform from In Line at Evercore ISI
ENTA Enanta
$71.21 /

+0.39 (+0.55%)

ENTA Enanta
$71.21 /

+0.39 (+0.55%)

Earnings
Capri Holdings sees FY23 EPS $6.85, consensus $6.74 » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
CPRI

Capri Holdings

$51.01 /

+1.38 (+2.78%)

Sees FY23 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/28/22 Barclays
Capri Holdings price target raised to $66 from $63 at Barclays
07/21/22 Credit Suisse
Capri Holdings price target lowered to $56 from $65 at Credit Suisse
07/21/22 Goldman Sachs
Capri Holdings price target lowered to $59 from $69 at Goldman Sachs
07/15/22 UBS
Capri Holdings price target lowered to $65 from $91 at UBS
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

Recommendations
Tyson Foods price target lowered to $95 from $100 at Stephens » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
TSN

Tyson Foods

$80.10 /

-7.395 (-8.45%)

Stephens analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

06:16 Today BMO Capital
Tyson Foods price target lowered to $90 from $99 at BMO Capital
05:55 Today Barclays
Tyson Foods price target lowered to $89 from $100 at Barclays
04:57 Today Piper Sandler
Piper upgrades Tyson Foods to Neutral with risks priced in
08/08/22 Piper Sandler
Tyson Foods upgraded to Neutral from Underweight at Piper Sandler
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

Recommendations
Reata Pharmaceuticals price target lowered to $27 from $37 at Baird » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
RETA

Reata Pharmaceuticals

$24.02 /

-11.895 (-33.12%)

Baird analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

08/08/22 Goldman Sachs
Reata sinks on Friedreich's ataxia update but Goldman remains positive
08/08/22 Goldman Sachs
Reata Pharmaceuticals price target raised to $76 from $73 at Goldman Sachs
05/27/22 Citi
Reata Pharmaceuticals price target raised to $46 from $43 at Citi
05/11/22 Ladenburg
Reata Pharmaceuticals price target lowered to $67 from $75 at Ladenburg
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

Hot Stocks
Wireless Telecom sees Q3 bookings $8M-$10M » 06:48
08/09/22
08/09
06:48
08/09/22
06:48
WTT

Wireless Telecom

$1.56 /

+0.08 (+5.41%)

Tim Whelan, CEO of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

Earnings
Capri Holdings reports Q1 adjusted EPS $1.50, consensus $1.36 » 06:47
08/09/22
08/09
06:47
08/09/22
06:47
CPRI

Capri Holdings

$51.01 /

+1.38 (+2.78%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/28/22 Barclays
Capri Holdings price target raised to $66 from $63 at Barclays
07/21/22 Credit Suisse
Capri Holdings price target lowered to $56 from $65 at Credit Suisse
07/21/22 Goldman Sachs
Capri Holdings price target lowered to $59 from $69 at Goldman Sachs
07/15/22 UBS
Capri Holdings price target lowered to $65 from $91 at UBS
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

Hot Stocks
Planet Fitness announces Jamie Medeiros as chief brand officer » 06:47
08/09/22
08/09
06:47
08/09/22
06:47
PLNT

Planet Fitness

$81.08 /

+0.71 (+0.88%)

Planet Fitness announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

07/07/22 Exane BNP Paribas
Planet Fitness upgraded to Neutral from Underperform at Exane BNP Paribas
06/13/22 Jefferies
Jefferies names five top picks in lifestyle and growth platforms
06/07/22 Cowen
Planet Fitness positioned to succeed despite macro challenges, says Cowen
05/25/22 Cowen
Planet Fitness operating model remains resilient among headwinds, says Cowen
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

Recommendations
Mersana Therapeutics price target raised to $20 from $18 at Baird » 06:47
08/09/22
08/09
06:47
08/09/22
06:47
MRSN

Mersana Therapeutics

$5.24 /

+0.215 (+4.28%)

, GSK

GSK plc

$40.31 /

-0.27 (-0.67%)

Baird analyst Collen Kusy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

05/10/22 Baird
Mersana Therapeutics price target lowered to $18 from $23 at Baird
05/09/22 H.C. Wainwright
Mersana price target lowered to $19 from $24 at H.C. Wainwright
11/10/21 Baird
Mersana Therapeutics price target lowered to $23 from $30 at Baird
10/14/21 BTIG
Mersana Therapeutics assumed with a Buy at BTIG
GSK GSK plc
$40.31 /

-0.27 (-0.67%)

08/08/22 UBS
GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS
08/05/22 Morgan Stanley
GSK plc resumed with an Equal Weight at Morgan Stanley
07/21/22 Citi
GSK plc resumed with a Neutral at Citi
07/20/22 UBS
GSK plc price target lowered to 1,850 GBp from 1,876 GBp at UBS
MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

Earnings
Wireless Telecom reports Q2 cont ops EPS (6c), consensus (4c) » 06:46
08/09/22
08/09
06:46
08/09/22
06:46
WTT

Wireless Telecom

$1.56 /

+0.08 (+5.41%)

Reports Q2 revenue $6.1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

Recommendations
Scholar Rock price target lowered to $43 from $55 at BMO Capital » 06:46
08/09/22
08/09
06:46
08/09/22
06:46
SRRK

Scholar Rock

$8.54 /

+0.035 (+0.41%)

BMO Capital analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRRK Scholar Rock
$8.54 /

+0.035 (+0.41%)

SRRK Scholar Rock
$8.54 /

+0.035 (+0.41%)

07/12/22 Truist
Scholar Rock initiated with a Buy at Truist
06/23/22 Piper Sandler
Scholar Rock price target lowered to $19 from $28 at Piper Sandler
05/24/22 JPMorgan
Scholar Rock price target lowered to $37 from $46 at JPMorgan
05/17/22 BMO Capital
Scholar Rock price target lowered to $55 from $74 at BMO Capital
SRRK Scholar Rock
$8.54 /

+0.035 (+0.41%)

Hot Stocks
Hormel Foods announces new operating model » 06:46
08/09/22
08/09
06:46
08/09/22
06:46
HRL

Hormel Foods

$49.03 /

+0.105 (+0.21%)

Hormel Foods announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HRL Hormel Foods
$49.03 /

+0.105 (+0.21%)

03/15/22 Goldman Sachs
Hormel Foods downgraded to Sell from Neutral at Goldman Sachs
03/10/22 Argus
Hormel Foods upgraded to Buy at Argus on pricing power
03/10/22 Argus
Hormel Foods upgraded to Buy from Hold at Argus
01/25/22 Piper Sandler
Hormel Foods price target lowered to $48 from $49 at Piper Sandler
HRL Hormel Foods
$49.03 /

+0.105 (+0.21%)

HRL Hormel Foods
$49.03 /

+0.105 (+0.21%)

HRL Hormel Foods
$49.03 /

+0.105 (+0.21%)

Downgrade
Nike downgraded to Neutral at Exane BNP Paribas on concerns about FY25 targets » 06:44
08/09/22
08/09
06:44
08/09/22
06:44
NKE

Nike

$114.01 /

+0.13 (+0.11%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$114.01 /

+0.13 (+0.11%)

NKE Nike
$114.01 /

+0.13 (+0.11%)

05:30 Today Exane BNP Paribas
Nike downgraded to Neutral from Outperform at Exane BNP Paribas
07/25/22 Piper Sandler
Nike assumed with a Neutral at Piper Sandler
07/21/22 KeyBanc
KeyBanc transitions coverage of Global Brands & E-Commerce with cautious view
07/20/22 KeyBanc
Nike initiated with a Sector Weight at KeyBanc
NKE Nike
$114.01 /

+0.13 (+0.11%)

NKE Nike
$114.01 /

+0.13 (+0.11%)

NKE Nike
$114.01 /

+0.13 (+0.11%)

NKE Nike
$114.01 /

+0.13 (+0.11%)

Earnings
Vivid Seats raises FY22 revenue view to $540.0M-$570.0M from $520.0M-$555.0M » 06:44
08/09/22
08/09
06:44
08/09/22
06:44
SEAT

Vivid Seats

$8.70 /

+0.18 (+2.11%)

Consensus is for FY22…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

07/14/22 Piper Sandler
Vivid Seats initiated with a Neutral at Piper Sandler
07/07/22 Citi
Vivid Seats price target lowered to $12 from $14 at Citi
05/10/22 Raymond James
Vivid Seats price target lowered to $11 from $17 at Raymond James
03/11/22 Benchmark
Vivid Seats price target lowered to $17 from $19 at Benchmark
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

Recommendations
Castle Biosciences price target raised to $48 from $44 at Baird » 06:44
08/09/22
08/09
06:44
08/09/22
06:44
CSTL

Castle Biosciences

$28.33 /

-2.34 (-7.63%)

Baird analyst Catherine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSTL Castle Biosciences
$28.33 /

-2.34 (-7.63%)

CSTL Castle Biosciences
$28.33 /

-2.34 (-7.63%)

05/19/22 Baird
Baird says final LCD for test 'incrementally positive' for Castle Biosciences
05/10/22 Canaccord
Castle Biosciences price target lowered to $65 from $80 at Canaccord
05/10/22 Baird
Castle Biosciences price target lowered to $44 from $50 at Baird
05/09/22 BTIG
Castle Biosciences transferred with a Buy at BTIG
CSTL Castle Biosciences
$28.33 /

-2.34 (-7.63%)

CSTL Castle Biosciences
$28.33 /

-2.34 (-7.63%)

Hot Stocks
Nielsen postpones court, special meeting regarding acquisition by consortium » 06:43
08/09/22
08/09
06:43
08/09/22
06:43
NLSN

Nielsen

$22.71 /

-0.33 (-1.43%)

Nielsen announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

05/16/22 BMO Capital
Nielsen downgraded to Market Perform from Outperform at BMO Capital
03/30/22 Jefferies
Nielsen downgraded to Hold from Buy at Jefferies
03/29/22 Morgan Stanley
Morgan Stanley raises Nielsen to Equal Weight, says 'may be better off private'
03/29/22 Morgan Stanley
Nielsen upgraded to Equal Weight from Underweight at Morgan Stanley
NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

Earnings
Hain Celestial sees FY23 low single digit adjusted net sales growth » 06:43
08/09/22
08/09
06:43
08/09/22
06:43
HAIN

Hain Celestial

$23.08 /

+0.1 (+0.44%)

FY23 outlook: The company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAIN Hain Celestial
$23.08 /

+0.1 (+0.44%)

06/16/22 Piper Sandler
Hain Celestial price target lowered to $31 from $36 at Piper Sandler
05/24/22 CL King
Hain Celestial initiated with a Buy at CL King
05/23/22 Cowen
Hain Celestial initiated with an Outperform at Cowen
05/09/22 Mizuho
Hain Celestial price target lowered to $31 from $44 at Mizuho
HAIN Hain Celestial
$23.08 /

+0.1 (+0.44%)

  • 11
    Nov
Recommendations
Targa Resources price target raised to $91 from $87 at Mizuho » 06:42
08/09/22
08/09
06:42
08/09/22
06:42
TRGP

Targa Resources

$65.03 /

+1.275 (+2.00%)

Mizuho analyst Gabriel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRGP Targa Resources
$65.03 /

+1.275 (+2.00%)

TRGP Targa Resources
$65.03 /

+1.275 (+2.00%)

07/20/22 Barclays
Targa Resources price target lowered to $87 from $92 at Barclays
07/12/22 RBC Capital
Targa Resources price target raised to $100 from $90 at RBC Capital
05/02/22 Truist
Targa Resources assumed with a Buy at Truist
04/26/22 Morgan Stanley
Targa Resources price target raised to $103 from $74 at Morgan Stanley
TRGP Targa Resources
$65.03 /

+1.275 (+2.00%)

TRGP Targa Resources
$65.03 /

+1.275 (+2.00%)

Earnings
Vivid Seats reports Q2 rvenue $147.7M, consensus $125.4M » 06:42
08/09/22
08/09
06:42
08/09/22
06:42
SEAT

Vivid Seats

$8.70 /

+0.18 (+2.11%)

Reports Q2 Adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

07/14/22 Piper Sandler
Vivid Seats initiated with a Neutral at Piper Sandler
07/07/22 Citi
Vivid Seats price target lowered to $12 from $14 at Citi
05/10/22 Raymond James
Vivid Seats price target lowered to $11 from $17 at Raymond James
03/11/22 Benchmark
Vivid Seats price target lowered to $17 from $19 at Benchmark
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

Recommendations
Pinnacle West price target raised to $77 from $76 at Mizuho » 06:41
08/09/22
08/09
06:41
08/09/22
06:41
PNW

Pinnacle West

$75.60 /

+0.215 (+0.29%)

Mizuho analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNW Pinnacle West
$75.60 /

+0.215 (+0.29%)

07/18/22 Barclays
Pinnacle West price target lowered to $68 from $78 at Barclays
06/30/22 UBS
Pinnacle West price target lowered to $67 from $74 at UBS
04/25/22 Credit Suisse
Pinnacle West initiated with an Underperform at Credit Suisse
04/19/22 Barclays
Pinnacle West downgraded to Underweight from Equal Weight at Barclays
PNW Pinnacle West
$75.60 /

+0.215 (+0.29%)

Earnings
Hain Celestial sees Q4 revenue approximately $457M, consensus $478.45M » 06:41
08/09/22
08/09
06:41
08/09/22
06:41
HAIN

Hain Celestial

$23.08 /

+0.1 (+0.44%)

Sees Q4 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAIN Hain Celestial
$23.08 /

+0.1 (+0.44%)

06/16/22 Piper Sandler
Hain Celestial price target lowered to $31 from $36 at Piper Sandler
05/24/22 CL King
Hain Celestial initiated with a Buy at CL King
05/23/22 Cowen
Hain Celestial initiated with an Outperform at Cowen
05/09/22 Mizuho
Hain Celestial price target lowered to $31 from $44 at Mizuho
HAIN Hain Celestial
$23.08 /

+0.1 (+0.44%)

  • 11
    Nov
Recommendations
Nvidia price target lowered to $250 from $290 at Mizuho » 06:41
08/09/22
08/09
06:41
08/09/22
06:41
NVDA

Nvidia

$177.97 /

-11.97 (-6.30%)

Mizuho analyst Vijay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

08/08/22 Summit Insights
Nvidia underestimated its exposure to crypto mining, says Summit Insights
08/08/22 Oppenheimer
Nvidia price target lowered to $250 from $300 at Oppenheimer
08/08/22 Truist
Nvidia price target lowered to $216 from $283 at Truist
08/08/22 Craig-Hallum
Craig-Hallum downgrades 'too expensive' Nvidia after guidance cut
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

Recommendations
Freshpet price target lowered to $90 from $100 at Baird » 06:41
08/09/22
08/09
06:41
08/09/22
06:41
FRPT

Freshpet

$56.39 /

+1.895 (+3.48%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

05/20/22 Atlantic Equities
Atlantic Equities sees more volatility for Freshpet, downgrades shares
05/20/22 Atlantic Equities
Freshpet downgraded to Neutral from Overweight at Atlantic Equities
05/03/22 Cowen
Freshpet price target lowered to $163 from $181 at Cowen
05/03/22 Oppenheimer
Freshpet price target lowered to $110 from $120 at Oppenheimer
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

  • 04
    May
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

Earnings
Planet Fitness sees FY22 adjusted EPS up mid-80% range » 06:40
08/09/22
08/09
06:40
08/09/22
06:40
PLNT

Planet Fitness

$81.08 /

+0.71 (+0.88%)

Sees FY22 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

07/07/22 Exane BNP Paribas
Planet Fitness upgraded to Neutral from Underperform at Exane BNP Paribas
06/13/22 Jefferies
Jefferies names five top picks in lifestyle and growth platforms
06/07/22 Cowen
Planet Fitness positioned to succeed despite macro challenges, says Cowen
05/25/22 Cowen
Planet Fitness operating model remains resilient among headwinds, says Cowen
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

Recommendations
LivePerson price target lowered to $14 from $18 at Mizuho » 06:40
08/09/22
08/09
06:40
08/09/22
06:40
LPSN

LivePerson

$16.54 /

+0.775 (+4.92%)

Mizuho analyst Siti…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPSN LivePerson
$16.54 /

+0.775 (+4.92%)

LPSN LivePerson
$16.54 /

+0.775 (+4.92%)

06:10 Today Loop Capital
LivePerson downgraded to Hold from Buy at Loop Capital
07/26/22 Jefferies
LivePerson price target lowered to $15 from $18 at Jefferies
05/23/22 Jefferies
LivePerson price target lowered to $18 from $23 at Jefferies
05/10/22 B. Riley
LivePerson price target lowered to $19 from $23 at B. Riley
LPSN LivePerson
$16.54 /

+0.775 (+4.92%)

LPSN LivePerson
$16.54 /

+0.775 (+4.92%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.